TXMD
TherapeuticsMD Inc is a women\'s health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.
TherapeuticsMD, Inc. (TXMD) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Growth (D-). The rating has held at C+ for 5 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | B (3.3) | D- (1.1) | B (3.3) | B- (2.9) | C+ (2.6) | C+ (2.7) |
| 2026-11-08 | B (3.3) | D- (1.1) | B (3.4) | B- (3.0) | C+ (2.6) | C+ (2.7) |
| 2026-11-01 | B (3.4) | D (1.2) | B (3.3) | B- (2.9) | C+ (2.7) | C+ (2.7) |
| 2026-10-25 | B (3.3) | D- (1.1) | B (3.4) | C+ (2.7) | C+ (2.6) | C+ (2.6) |
| 2026-10-18 | B (3.3) | D- (1.1) | B (3.3) | C+ (2.8) | C+ (2.6) | C+ (2.6) |